Wyeth Effexor Promotion Cited By U.K. Health Authorities
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicines & Healthcare products Regulatory Agency says venlafaxine promotion was found to "openly question" recommendations for restricted use of the antidepressant in cardiovascular patients. Wyeth says it was in the process of updating promotional material to reflect new labeling when the violation occurred.